Toni Choueiri, Medical Doctor and Professor at Dana-Farber Cancer Institute, recently posted on LinkedIn:
“51 years in the making till GU24. OS benefit in adjuvant Renal Cancer is finally here.
Lucky to be part of this journey. Gratitude to patients and families that go on trials. Thank you!”
Source: Toni Choueiri/LinkedIn